Jaguar Health
JAGX
1 hedge funds and large institutions have $1.74M invested in Jaguar Health in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
757% more call options, than puts
Call options by funds: $120K | Put options by funds: $14K
0% more ownership
Funds ownership: 0% → 0% (+0%)
56% less capital invested
Capital invested by funds: $3.94M → $1.74M (-$2.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$81K |
| 2 |
VCM
Virtue Capital Management
Brentwood,
Tennessee
|
-$35K |
| 3 |
Citigroup
New York
|
-$34K |
| 4 |
Jane Street
New York
|
-$23K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$12K |
JAGX Hedge Fund Activity: Q2 2022 in Review
1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2022, worth a combined $1.74M — down 56% from $3.94M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new JAGX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1.51M. The largest seller was Principal Financial Group, cutting an estimated $81K.
- 1 institutional investor held Jaguar Health (JAGX) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $1.74M of Jaguar Health stock for Q2 2022, down 56% quarter-over-quarter.
- 1 fund opened new Jaguar Health positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Jaguar Health buyer in Q2 2022 was Vanguard Group, an estimated $1.51M added.
- The largest Jaguar Health seller in Q2 2022 was Principal Financial Group, an estimated $81K sold.
Based on aggregated 13F filings for Q2 2022.